Publications

Filtres: Autor és Porta, M [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

P

Porta M, Hernández-Aguado I, Lumbreras B, Crous-Bou M. "Omics" research, monetization of intellectual property and fragmentation of knowledge: can clinical epidemiology strengthen integrative research? Journal of clinical epidemiology. 2007;60(12):1220-5; discussion 1226-8. Abstract

Porta M, Ferrer-Armengou O, Pumarega J, López T, Crous-Bou M, Alguacil J, et al. Exocrine pancreatic cancer clinical factors were related to timing of blood extraction and influenced serum concentrations of lipids. Journal of clinical epidemiology. 2008;61(7):695-704. Abstract

Porta M, Crous-Bou M, Wark PA, Vineis P, Real FX, Malats N, et al. Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: etiopathogenic similarities, differences and paradoxes. Mutation research. 2009;682(2-3):83-93. Abstract

Porta M, Vandenbroucke JP, Ioannidis JP, Sanz S, Fernandez E, Bhopal R, et al. Trends in citations to books on epidemiological and statistical methods in the biomedical literature. PloS one. 2013;8(5):e61837. Abstract

Porta M, López T, Pumarega J, Jariod M, Crous-Bou M, Marco E, et al. In pancreatic ductal adenocarcinoma blood concentrations of some organochlorine compounds and coffee intake are independently associated with KRAS mutations. Mutagenesis. 2009;24(6):513-21. Abstract

Pérez G, Porta M, Borrell C, Casamitjana M, Bonfill X, Bolibar I, et al. Interval from diagnosis to treatment onset for six major cancers in Catalonia, Spain. Cancer detection and prevention. 2008;32(3):267-75. Abstract

Parker LA, Porta M, Lumbreras B, López T, Guarner L, Hernández-Aguado I, et al. Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients. European Journal of Epidemiology. 2011;26(3):229-36. Abstract

M

Morales E, Porta M, Vioque J, López T, Mendez MA, Pumarega J, et al. Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer. Journal of epidemiology and community health. 2007;61(7):641-9. Abstract

Martrat G, Maxwell CA, Tominaga E, Porta M, Bonifaci N, Gomez-Baldo L, et al. Exploring the link between MORF4L1 and risk of breast cancer. Breast cancer research : BCR. 2011;13(2):R40. Abstract

C

Crous-Bou M, De Vivo I, Porta M, Pumarega JA, López T, Alguacil J, et al. CYP1B1 polymorphisms and k-ras mutations in patients with pancreatic ductal adenocarcinoma. Digestive diseases and sciences. 2008;53(5):1417-21. Abstract

Crous-Bou M, Porta M, López T, Jariod M, Malats N, Morales E, et al. Lifetime history of alcohol consumption and K-ras mutations in pancreatic ductal adenocarcinoma. Environmental and molecular mutagenesis. 2009;50(5):421-30. Abstract

Crous-Bou M, Porta M, López T, Jariod M, Malats N, Alguacil J, et al. Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer. Pancreas. 2007;35(2):135-41. Abstract

Crous-Bou M, Porta M, Morales E, López T, Carrato A, Puigdomènech E, et al. Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study. Cancer causes & control : CCC. 2009;20(5):591-9. Abstract